Quick Answer
Fresenius Medical Care AG reported Net Income of $1.24 billion for fiscal year 2016.
Fresenius Medical Care AG — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | — | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — | — |
| Total Assets | $31.00B -7.6% |
$33.57B -1.1% |
$33.93B -5.1% |
$35.75B +4.0% |
$34.37B +8.4% |
$31.69B -3.8% |
| Cash and Equivalents | — | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | — | — | — | — | — | — |
| R&D Expense | $157.97M -13.9% |
$183.49M -20.9% |
$231.97M +1.5% |
$228.62M +3.6% |
$220.78M +13.9% |
$193.77M +15.3% |
| Operating Income | — | — | — | — | — | — |
| Gross Profit | — | — | — | $5.31B +4.6% |
$5.08B -8.3% |
$5.54B +2.6% |
| Shares Outstanding | — | — | — | — | — | — |
- Fresenius Medical Care AG reported Net Income of $1.24 billion for fiscal year 2016.
- Fresenius Medical Care AG showed an increase of +20.8% in Net Income compared to the prior fiscal year.
- Fresenius Medical Care AG reported Diluted EPS of $3.45 per share for fiscal year 2014.
- Fresenius Medical Care AG showed a decrease of -5.5% in Diluted EPS compared to the prior fiscal year.
- Fresenius Medical Care AG reported Total Assets of $31.00 billion for fiscal year 2025.
- Fresenius Medical Care AG showed a decrease of -7.6% in Total Assets compared to the prior fiscal year.
- Fresenius Medical Care AG reported Cash and Equivalents of $747.23 million for fiscal year 2016.
- Fresenius Medical Care AG showed an increase of +36.0% in Cash and Equivalents compared to the prior fiscal year.
- Fresenius Medical Care AG reported Long-Term Debt of $7.20 billion for fiscal year 2016.
- Fresenius Medical Care AG showed a decrease of -8.3% in Long-Term Debt compared to the prior fiscal year.
- Fresenius Medical Care AG reported Stockholders Equity of $10.81 billion for fiscal year 2016.
- Fresenius Medical Care AG showed an increase of +9.3% in Stockholders Equity compared to the prior fiscal year.
- Fresenius Medical Care AG reported R&D Expense of $157.97 million for fiscal year 2025.
- Fresenius Medical Care AG showed a decrease of -13.9% in R&D Expense compared to the prior fiscal year.
- Fresenius Medical Care AG reported Operating Income of $2.64 billion for fiscal year 2016.
- Fresenius Medical Care AG showed an increase of +13.4% in Operating Income compared to the prior fiscal year.
- Fresenius Medical Care AG reported Gross Profit of $5.31 billion for fiscal year 2022.
- Fresenius Medical Care AG showed an increase of +4.6% in Gross Profit compared to the prior fiscal year.
- Fresenius Medical Care AG reported Shares Outstanding of 306.22 million shares for fiscal year 2016.
- Fresenius Medical Care AG showed an increase of +0.3% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: